ClinicalTrials.gov
public full text
Public Domain
Prevention of Persistence of Bacterial Vaginosis
This purpose of this study will be to conduct a double-blind, randomized, controlled clinical trial to determine the association between intravaginal high dose metronidazole (750mg), intravaginal high dose metronidazole combined with an antifungal agent(750mg metronidazole + 200mg miconazole) and low dose (37.5mg) intravaginal metronidazole, with the rate of persistent bacterial vaginosis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Pilot Study of Oral Tinidazole for Women With Recurrent Bacterial Vaginosis#1171551
- Trichomonas Vaginalis Recurrence Among HIV+ Women#1093452
- Treatment of Bacterial Vaginosis Prior to Active Labor and Infectious Morbidity#852447
- 11 combinatii (metamizol sodic, cafeina, drotaverina) 400mg/60mg/40mg - cp#367402
- metronidazol 5 mg/ml 300 ml perfusion intravenosa#296872
Record · ID 875506
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive